Milan, February 26th 2019 – NTC Srl, an Italian pharmaceutical company with significant expertise in research and development in ophthalmology, announces today a commercial partnership with Bruno Farmaceutici S.p.A.
During FacoElche Congress (31st January – 2nd February 2019), NTC Ophthalmics Ibérica organized its first Symposium focused on the rational use of topical antibiotics in ophthalmology.
One month passed since last CPhI in Madrid. There, NTC team met more than 200 potential customers and suppliers coming from 50 countries all over the world.
NTC, the Italian pharmaceutical company, presented at the ESCRS (European Society of Cataract & Refractive Surgeons) Congress of Vienna the protocol of Leader7, one of the largest clinical trials in ophthalmology at European level of the last decade.